BioElectronics

Please join us in wishing Dr. Richard Staelin, Chairman of BioElectronics Corporation, a very happy 87th birthday today!

We are deeply grateful for Rick’s wisdom, patience, guidance, and steady support in the management of BioElectronics Corporation. His experience and thoughtful counsel have been invaluable to our company and to all of us who have had the privilege of working with him.

We continue to admire his remarkable energy, strong work ethic, and genuine goodness as a human being. Rick leads with intelligence, integrity, kindness, and a sincere commitment to BioElectronics and its shareholders.

Happy 87th birthday, Rick! We wish you a wonderful day and many more healthy and happy years ahead.

https://www.newmediawire.com/news/bioelectronics-corporation-doubles-facility-space-to-support-electrome-s-commercial-actipatch-launch-and-anticipated-sales-growth-7087843

BioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial ActiPatch Launch and Anticipated Sales Growth JEFFERSON, MD - July 21, 2026 (NEWMEDIAWIRE) - BioElectronics Corporation (https://www.bielcorp.com/) OTC: BIEL a developer of medical technology products, announces today that it has expanded its Maryland headquarters by leasing the adjacent office suite. The additional space will operate as a dedi...

BioElectronics obtained the FDA clearances necessary to legally market our products. That process takes time, evidence, regulatory discipline, and accountability. Companies that skip that process while making medical claims should not get a free pass.

Consumers deserve truthful advertising.

Legitimate medical device companies deserve a level playing field.

BioElectronics Corporation wishes our valued customers, vendors, distribution partners, and shareholders a safe and happy Independence Day holiday weekend.

As we celebrate the birth of our great nation, we honor the freedoms, perseverance, and spirit that continue to inspire us all.

Happy 4th of July!

https://finance.yahoo.com/healthcare/articles/bioelectronics-issues-chairmans-highlighting-sales-121500110.html

BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress JEFFERSON, MD - June 30, 2026 (NEWMEDIAWIRE) - BioElectronics Corporation (https://www.bielcorp.com/) (OTC: BIEL), a developer of medical technology products, today released an update from its Chairman, Richard Staelin, PhD. Dear Shareholders,It has ...

Contact us for more information: 301 874-4890 or [email protected]

https://www.instagram.com/reels/DYztFgQjMb1/

RecoveryRx is a game changer

Today, we pause to remember and honor the brave men and women who made the ultimate sacrifice for our country. We reflect with gratitude on the freedoms we enjoy because of those who gave everything to protect them.

From all of us at BioElectronics Corporation, we wish you and your family a safe, meaningful, and reflective Memorial Day.

We’ve officially announced the expansion of ActiPatch® into Taiwan—bringing FDA-cleared, drug-free pain therapy to a new and growing international market.

This launch represents a key step in our growth strategy—partnering with high-quality distributors to deliver non-invasive, long-duration pain relief to patients who are actively seeking alternatives to drugs.

ActiPatch delivers:
✔️ Up to 720 hours of continuous therapy
✔️ Drug-free, non-invasive pain relief
✔️ No sensation, no disruption to daily life
✔️ Proven use across musculoskeletal conditions

As healthcare systems worldwide look to reduce reliance on opioids and NSAIDs, demand for safe, effective alternatives continues to grow.

👉 We are actively seeking distribution partners in additional markets

If you have reach in:
• Retail pharmacy
• Medical / DME distribution
• International markets
• Physical therapy, chiropractic, or surgical networks

We want to connect. This is a proven, FDA-cleared platform ready to scale. [email protected] or 301.874.4890

The BioElectronics R&D team is seeking a physician or clinical researcher who is interested in collaborating on a vulvodynia-focused study to evaluate the effectiveness of RecoveryRx for treating vulvodynia pain.

RecoveryRx is a class II, USA FDA-cleared, drug-free, non-invasive, disposable, non-thermal shortwave therapy device that utilizes radio-frequency electromagnetic energy to modulate nerve activity. When used adjunctively, RecoveryRx has been found to reduce pain and the consumption of pain medication, including opioids. Our current published clinical data can be viewed at www.bielcorp.com

We’re working on a grant proposal for the National Vulvodynia Association and seek to partner with a medical professional who is excited about turning good clinical ideas into real-world evidence. This is an early-stage collaboration meaning no finalized protocol, no overwhelming paperwork (yet!), and no heavy upfront commitment. Just shared interest, clinical insight, and a desire to improve care for patients who truly need better options.

Please contact us at 301.874.4890 or email us at [email protected]

As we welcome the New Year, we want to extend our sincere thanks and warmest wishes to our shareholders, vendors, and distribution partners. Your trust, collaboration, and continued support make everything we do possible. We’re grateful for the partnerships we’ve built and EXCITED FOR THE OPPORTUNITIES AHEAD. Wishing you and your families a Happy New Year filled with health, success, and shared growth. 🎉